{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:04:03Z","timestamp":1774364643642,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Importance:<\/jats:title>\n            <jats:p>Adults hospitalized with sepsis\/septic shock commonly develop acute kidney injury (AKI) which imposes a significant burden on the healthcare system. The administration of early human albumin in this patient population may yield more efficient healthcare resource utilization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To examine the association between early use of albumin and time to discharge in adults who develop severe AKI while hospitalized with sepsis\/septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective cohort study using de-identified electronic health records from a national database (Cerner Health Facts; Cerner Corp., Kansas City, MO).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting and Participants:<\/jats:title>\n            <jats:p>Patients (<jats:italic toggle=\"yes\">n<\/jats:italic> = 2,829) hospitalized between January 2013 and April 2018 with a diagnosis of sepsis\/septic shock (identified using <jats:italic toggle=\"yes\">International Classification of Diseases<\/jats:italic>, 9th Revision and 10th Revision codes) who developed severe AKI (stage 3 according to Kidney Disease Improving Global Outcomes criteria) during hospitalization (<jats:italic toggle=\"yes\">n<\/jats:italic> = 2,845 unique encounters).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main Outcomes and Measures:<\/jats:title>\n            <jats:p>Patients were grouped according to timing of albumin exposure: within less than or equal to 24 hours of admission (\u201cearly albumin\u201d) or unexposed\/exposed late (\u201cnonearly albumin\u201d). A cause-specific hazard model, censoring for death\/discharge to hospice, was used to examine the association between \u201cearly albumin\u201d and the rate of hospital discharge with clinical stability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Albumin was administered early in 8.6% of cases. Cases with early albumin administration had a median time to discharge of 13.2 days compared with 17.0 in the nonearly group (Log-rank <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001). An adjusted analysis showed that the rate of hospital discharge with clinical stability increased by 83% in the early albumin group compared with the nonearly group (hazard ratio, 1.832; 95% CI, 1.564\u20132.146; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001 nonearly group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions and Relevance:<\/jats:title>\n            <jats:p>The use of albumin within 24 hours of hospital admission was associated with a shorter time to discharge and a higher rate of discharge with clinical stability, suggesting an improvement in healthcare resource utilization among patients with sepsis\/septic shock who developed stage 3 AKI during hospitalization.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000793","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T19:05:28Z","timestamp":1697742328000},"page":"e0793","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Early Albumin Infusion Is Associated With Greater Survival to Discharge Among Patients With Sepsis\/Septic Shock Who Develop Severe Acute Kidney Injury Among Patients With Sepsis\/Septic Shock Who Develop Severe Acute Kidney Injury"],"prefix":"10.1097","volume":"4","author":[{"given":"Karthik","family":"Raghunathan","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Duke University, Durham, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan A.","family":"Kempker","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Anne","family":"Davis","sequence":"additional","affiliation":[{"name":"Grifols Shared Services North America (SSNA), Research Triangle Park, Durham, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navreet S.","family":"Sindhwani","sequence":"additional","affiliation":[{"name":"Grifols Shared Services North America (SSNA), Research Triangle Park, Durham, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Telang","sequence":"additional","affiliation":[{"name":"Boston Strategic Partners, Inc, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Lodaya","sequence":"additional","affiliation":[{"name":"Boston Strategic Partners, Inc, Boston, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg S.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"e187571","DOI":"10.1001\/jamanetworkopen.2018.7571","article-title":"Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals","volume":"2","author":"Rhee","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"e206004","DOI":"10.1001\/jamanetworkopen.2020.6004","article-title":"Assessment of health care exposures and outcomes in adult patients with sepsis and septic shock","volume":"3","author":"Fay","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: Inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MCC.0000000000000153","article-title":"Sepsis-induced acute kidney injury revisited: Pathophysiology, prevention and future therapies","volume":"20","author":"Zarbock","year":"2014","journal-title":"Curr Opin Crit Care"},{"key":"R6-20240807","first-page":"125","article-title":"Sepsis and inflammation: Impact on acute kidney injury","volume":"40","author":"Dirkes","year":"2013","journal-title":"Nephrol Nurs J"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semnephrol.2015.01.003","article-title":"Clinical approach to the patient with AKI and sepsis","volume":"35","author":"Godin","year":"2015","journal-title":"Semin Nephrol"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/TA.0b013e31829de6cd","article-title":"Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis","volume":"75","author":"White","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/cc6863","article-title":"Early acute kidney injury and sepsis: A multicentre evaluation","volume":"12","author":"Bagshaw","year":"2008","journal-title":"Crit Care"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0885066616645308","article-title":"Impact of end-stage renal disease and acute kidney injury on ICU outcomes in patients with sepsis","volume":"32","author":"Jeganathan","year":"2017","journal-title":"J Intensive Care Med"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"e0176292","DOI":"10.1371\/journal.pone.0176292","article-title":"Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study","volume":"12","author":"Hammond","year":"2017","journal-title":"PLoS One"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MCC.0b013e328332f686","article-title":"Colloids and crystalloids: Does it matter to the kidney?","volume":"15","author":"Roche","year":"2009","journal-title":"Curr Opin Crit Care"},{"key":"R13-20240807","first-page":"216","article-title":"Recommendations for the use of albumin and immunoglobulins","volume":"7","author":"Liumbruno","year":"2009","journal-title":"Blood Transfus"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcrc.2016.04.019","article-title":"Fluid management in sepsis: The potential beneficial effects of albumin","volume":"35","author":"Vincent","year":"2016","journal-title":"J Crit Care"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1186\/s13054-014-0702-y","article-title":"Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: A meta-analysis of randomized clinical trials","volume":"18","author":"Xu","year":"2014","journal-title":"Crit Care"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcrc.2018.11.031","article-title":"Crystalloids vs. colloids for fluid resuscitation in the intensive care unit: A systematic review and meta-analysis","volume":"50","author":"Martin","year":"2019","journal-title":"J Crit Care"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/CCM.0000000000004224","article-title":"Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012-2018","volume":"48","author":"Buchman","year":"2020","journal-title":"Crit Care Med"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/cc6863","article-title":"Early acute kidney injury and sepsis: A multicentre evaluation","volume":"12","author":"Bagshaw","year":"2008","journal-title":"Crit Care"},{"key":"R22-20240807","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Inter Suppl"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jhin.2005.12.016","article-title":"Cost of intensive care unit-acquired bloodstream infections","volume":"63","author":"Laupland","year":"2006","journal-title":"J Hosp Infect"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc11333","article-title":"Higher vs. lower fluid volume for septic shock: Clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort","volume":"16","author":"Smith","year":"2012","journal-title":"Crit Care"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"24083","DOI":"10.1038\/s41598-021-03122-0","article-title":"Association between albumin infusion and outcomes in patients with acute kidney injury and septic shock","volume":"11","author":"Ge","year":"2021","journal-title":"Sci Rep"},{"key":"R26-20240807","first-page":"CD000567","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill patients","author":"Perel","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/00003246-200210000-00001","article-title":"Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury","volume":"30","author":"Martin","year":"2002","journal-title":"Crit Care Med"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/01.CCM.0000171539.47006.02","article-title":"A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury","volume":"33","author":"Martin","year":"2005","journal-title":"Crit Care Med"},{"key":"R29-20240807","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/cc13991","article-title":"Albumin administration in the acutely ill: What is new and where next?","volume":"18","author":"Vincent","year":"2014","journal-title":"Crit Care"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"R32-20240807","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcrc.2006.11.005","article-title":"The COASST study: Cost-effectiveness of albumin in severe sepsis and septic shock","volume":"22","author":"Guidet","year":"2007","journal-title":"J Crit Care"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1574887108666131213120816","article-title":"Choice of fluids in severe septic patients - A cost-effectiveness analysis informed by recent clinical trials","volume":"9","author":"Farrugia","year":"2014","journal-title":"Rev Recent Clin Trials"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ndt\/gfu314","article-title":"Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients","volume":"30","author":"Ethgen","year":"2015","journal-title":"Nephrol Dial Transplant"}],"updated-by":[{"DOI":"10.1097\/cce.0000000000000852","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000}}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:04:33Z","timestamp":1723039473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000793","relation":{"correction":[{"id-type":"doi","id":"10.1097\/CCE.0000000000000852","asserted-by":"object"}]},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}